These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26835590)

  • 21. Bikunin loss in urine as useful marker for bladder carcinoma.
    Tsui KH; Tang P; Lin CY; Chang PL; Chang CH; Yung BY
    J Urol; 2010 Jan; 183(1):339-44. PubMed ID: 19914646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 activity in urine and serum in patients with bladder carcinoma.
    Seguchi T; Yokokawa K; Sugao H; Nakano E; Sonoda T; Okuyama A
    J Urol; 1992 Sep; 148(3):791-4. PubMed ID: 1512827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of bladder cancer by analysis of urinary fibronectin.
    Menéndez V; Fernández-Suárez A; Galán JA; Pérez M; García-López F
    Urology; 2005 Feb; 65(2):284-9. PubMed ID: 15708039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of autocrine motility factor in urine as a marker of bladder cancer.
    Guirguis R; Schiffmann E; Liu B; Birkbeck D; Engel J; Liotta L
    J Natl Cancer Inst; 1988 Oct; 80(15):1203-11. PubMed ID: 3138430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of surface plasmon resonance imaging biosensors for determination of fibronectin, laminin-5 and type IV collagen in serum of transitional bladder cancer patients.
    Guszcz T; Sankiewicz A; Gorodkiewicz E
    J Pharm Biomed Anal; 2023 Jan; 222():115103. PubMed ID: 36272276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer.
    Tsumura H; Matsumoto K; Ikeda M; Yanagita K; Hirano S; Hagiwara M; Nagashio R; Fujita T; Sato Y; Iwamura M
    Asian Pac J Cancer Prev; 2015; 16(4):1539-43. PubMed ID: 25743828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
    Kouba EJ; Lentz A; Wallen EM; Pruthi RS
    Urol Oncol; 2009; 27(5):486-90. PubMed ID: 18555706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of CA 125 in transitional cell carcinoma of the bladder.
    Manvar AM; Wallen EM; Pruthi RS; Nielsen ME
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1877-81. PubMed ID: 21110754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
    Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Bruins JL; Kester AD; Janknegt R
    Eur Urol; 1992; 21(3):240-4. PubMed ID: 1499633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
    Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
    Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique.
    Tokarzewicz A; Guszcz T; Onopiuk A; Kozlowski R; Gorodkiewicz E
    Indian J Med Res; 2018 Jan; 147(1):46-50. PubMed ID: 29749360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R; Shariat SF; Monoski MA; Lerner SP
    Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
    Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
    BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre and postoperative quantitative detection of fragments of cytokeratins 8 and 18 (UBC IRMA) as markers of early recurrence of superficial bladder tumor.
    Gacci M; Serni S; Lapini A; Giubilei G; Dal Canto M; Paladini S; Curotto A; Gallo F; Carmignani G; Carini M
    Arch Ital Urol Androl; 2006 Mar; 78(1):5-10. PubMed ID: 16752880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.
    Pariente JL; Bordenave L; Michel P; Latapie MJ; Ducassou D; Le Guillou M
    J Urol; 1997 Aug; 158(2):338-41. PubMed ID: 9224298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
    Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H; Kor K; Djalali M
    Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.